Login To Trade  |  About IIFL
  • NIFTY  7655.05  -167.95 -2.15%
  • SENSEX 25201.9  -562.88 -2.18%
  1. News
  2. Sector

  3. FMCG

Nestle India to consider accquistion of healthcare nutrition business

India Infoline News Service | Mumbai | November 30, 2009 17:29 IST

The product portfolio under the Healthcare Nutrition Business is meant to satisfy the needs of consumers with special nutritional requirements and sold in India under brands like RESOURCE, OPTIFAST, SPERT

The meeting of the Board of Directors of Nestle India Ltd will be held on December 07, 2009, inter-alia, to consider the proposal of Speciality Foods India Pvt. Ltd. for a possible acquisition of its Healthcare Nutrition Business (revenue for the year ended March 31, 2009 - Rs288mn) by Nestle India Ltd., on terms and conditions as may be mutually agreed.

The product portfolio under the Healthcare Nutrition Business is meant to satisfy the needs of consumers with special nutritional requirements and sold in India under brands like RESOURCE, OPTIFAST, SPERT.

BSE 5,994.50 [32.60] ([0.54]%)
NSE 5,995.60 [39.85] ([0.66]%)

***Note: This is a NSE Chart


Get Top 500 Company Research from acclaimed IIFL Research Team...Click Here!!!

Read more on: Nestle  India 
article
113092901957
Nestle India to consider accquistion of healthcare nutrition business
Nestle India to consider accquistion of healthcare nutrition business
The product portfolio under the Healthcare Nutrition Business is meant to satisfy the needs of consumers with special nutritional requirements and sold in India under brands like RESOURCE, OPTIFAST, SPERT
http://www.indiainfoline.com/article/news-business/nestle-india-to-consider-accquistion-of-healthcare-nutrition-business-113092901957_1.html
November 30, 2009 17:29 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
Nestle India Ltd
FMCG
$rawVideoFileUrl$
$videoPlayerUrl$
News
Recent Reports

Stability in US and Europe to aid export growth

India Infoline Research Team / 10:47, Aug 24, 2015

In spite of massive improvement in CV demand, standalone revenues for Banco Products Ltd registered muted performance with sales at Rs. 113cr in Q1 FY16.